$ABBV stock has now fallen 3% today, according to our price data from Polygon. There has been approximately $642,113,006 of trading volume.
It has been the 407th most-searched ticker on Quiver Quantitative over the last day, out of 11,889 total tickers searched.
Here is what we see in our data on $ABBV (you can track the company live on Quiver's $ABBV stock page):
$ABBV Insider Trading Activity
$ABBV insiders have traded $ABBV stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:
- PERRY C SIATIS (EVP, GC AND SECRETARY) has made 0 purchases and 3 sales selling 18,668 shares for an estimated $4,375,549.
- DAVID RYAN PURDUE (SVP, Controller) sold 5,230 shares for an estimated $1,221,518
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABBV Hedge Fund Activity
We have seen 1,706 institutional investors add shares of $ABBV stock to their portfolio, and 1,744 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 37,400,173 shares (-74.3%) from their portfolio in Q4 2025, for an estimated $8,545,565,528
- CAPITAL WORLD INVESTORS added 6,736,161 shares (+106.3%) to their portfolio in Q4 2025, for an estimated $1,539,145,426
- BLACKROCK, INC. added 5,197,454 shares (+3.6%) to their portfolio in Q4 2025, for an estimated $1,187,566,264
- CARDANO RISK MANAGEMENT B.V. added 4,908,260 shares (+914.6%) to their portfolio in Q4 2025, for an estimated $1,121,488,327
- WELLINGTON MANAGEMENT GROUP LLP added 4,389,782 shares (+41.7%) to their portfolio in Q4 2025, for an estimated $1,003,021,289
- GEODE CAPITAL MANAGEMENT, LLC added 4,190,487 shares (+10.4%) to their portfolio in Q4 2025, for an estimated $957,484,374
- JPMORGAN CHASE & CO removed 4,141,493 shares (-7.3%) from their portfolio in Q4 2025, for an estimated $946,289,735
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABBV Government Contracts
We have seen $303,466 of award payments to $ABBV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROSTHETIC ORDER - IMPLANT ITEMS: $15,758
- 4567881995!NATRELLE TE SMOOTH 133S-MV-15-T: $13,170
- 4567953518!NATRELLE INSPIRA SSL 230CC BREAST IMPLAN: $12,888
- BREAST IMPLANTS: $10,935
- 4568645077!NATRELLE TE SMOOTH 133S-MV-11-T: $9,109
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$ABBV Congressional Stock Trading
Members of Congress have traded $ABBV stock 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 12/08.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ABBV Analyst Ratings
Wall Street analysts have issued reports on $ABBV in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HSBC issued a "Buy" rating on 12/10/2025
- Guggenheim issued a "Buy" rating on 10/20/2025
- Piper Sandler issued a "Overweight" rating on 10/10/2025
To track analyst ratings and price targets for $ABBV, check out Quiver Quantitative's $ABBV forecast page.
$ABBV Price Targets
Multiple analysts have issued price targets for $ABBV recently. We have seen 13 analysts offer price targets for $ABBV in the last 6 months, with a median target of $260.0.
Here are some recent targets:
- Trung Huynh from RBC Capital set a target price of $260.0 on 02/25/2026
- Emily Field from Barclays set a target price of $275.0 on 02/20/2026
- David Amsellem from Piper Sandler set a target price of $299.0 on 02/18/2026
- Michael Yee from UBS set a target price of $230.0 on 02/05/2026
- Terence Flynn from Morgan Stanley set a target price of $270.0 on 02/05/2026
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $228.0 on 02/05/2026
- Geoff Meacham from Citigroup set a target price of $230.0 on 01/27/2026
You can track data on $ABBV on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
